tiprankstipranks
Trending News
More News >
Context Therapeutics (DE:6K9)
FRANKFURT:6K9
Germany Market
Advertisement

Context Therapeutics (6K9) Technical Analysis

Compare
1 Followers

Summary of all the Indicators

Overall Consensus
Buy
13Bullish
3Neutral
6Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Context Therapeutics’s (6K9) Moving Averages Convergence Divergence (MACD) indicator is 0.04, suggesting Context Therapeutics is a Sell.
Context Therapeutics’s (6K9) 20-Day exponential moving average is 0.75, while Context Therapeutics’s (6K9) share price is €0.82, making it a Buy.
Context Therapeutics’s (6K9) 50-Day exponential moving average is 0.70, while Context Therapeutics’s (6K9) share price is €0.82, making it a Buy.

Context Therapeutics (6K9) Pivot Points

Oct 06, 2025, 05:08 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.76
0.77
0.80
0.82
0.84
0.86
0.89
Fibonacci
0.77
0.79
0.80
0.82
0.83
0.84
0.86
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Context Therapeutics (6K9) Moving Averages

Oct 06, 2025, 05:08 PM
Period
Simple
Exponential
MA5
0.79Buy
0.80Buy
MA10
0.78Buy
0.78Buy
MA20
0.74Buy
0.75Buy
MA50
0.68Buy
0.70Buy
MA100
0.61Buy
0.69Buy
MA200
0.69Buy
0.85Sell
Context Therapeutics’s (6K9) 10-Day exponential moving average is 0.78, while Context Therapeutics’s (6K9) share price is €0.82, making it a Buy.
Context Therapeutics’s (6K9) 100-Day exponential moving average is 0.69, while Context Therapeutics’s (6K9) share price is €0.82, making it a Buy.
Context Therapeutics’s (6K9) stock price is €0.82 and Context Therapeutics’s (6K9) 50-day simple moving average is 0.68, creating a Buy signal.
Context Therapeutics’s (6K9) stock price is €0.82 and Context Therapeutics’s (6K9) 100-day simple moving average is 0.61, creating a Buy signal.
Context Therapeutics’s (6K9) stock price is €0.82 and Context Therapeutics’s (6K9) 200-day simple moving average is 0.69, creating a Buy signal.

Context Therapeutics (6K9) Technical Indicators

Oct 06, 2025, 05:08 PM
Name
Value
Implied Action
RSI (14)
63.58
Neutral
STOCH (9,6)
85.48
Sell
STOCHRSI (14)
91.54
Sell
MACD (12,26)
0.04
Sell
ADX (14)
26.47
Neutral
Williams %R
-10.00
Sell
CCI (14)
103.62
Sell
ATR (14)
0.02
-
Ultimate Oscillator
61.91
Neutral
ROC
19.85
Buy
Context Therapeutics’s (6K9) Relative Strength Index (RSI) is 63.58, creating a Neutral signal.
Context Therapeutics’s (6K9) Trend Strength Indicator (ADX) is 26.47, creating a Neutral signal.
Context Therapeutics’s (6K9) Commodity Channel Index (CCI) is 103.62, creating a Sell signal.
Context Therapeutics’s (6K9) Price Rate of Change (ROC) is 19.85, creating a Buy signal.

FAQ

Is 6K9 a Buy, Hold, or Sell?
Based on 6K9’s technical indicators, 6K9 is a Buy.
    What is 6K9’s RSI (14)?
    6K9’s RSI (14) is 63.58, which suggests 6K9 is a Neutral.
      What is 6K9’s MACD?
      6K9’s MACD is 0.04, which suggests 6K9 is a Sell.
        What is 6K9’s 5-day moving average?
        6K9’s 5-day moving average is 0.79, which suggests 6K9 is a Buy.
          What is 6K9’s 20-day moving average?
          6K9 20-day moving average is 0.74, which suggests 6K9 is a Buy.
            What is 6K9’s 50-day moving average?
            6K9’s 50-day moving average is 0.68, which suggests 6K9 is a Buy.
              What is 6K9’s 200-day moving average?
              6K9’s 200-day moving average is 0.69, which suggests 6K9 is a Buy.
                What is 6K9’s Williams % R (14)?
                6K9’s Williams % R (14) is -10.00, which suggests 6K9 is a Sell.
                  What is 6K9’s CCI (14)?
                  6K9’s CCI (14) is 103.62, which suggests 6K9 is a Sell.
                    What is the share price of Context Therapeutics?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis